1. Home
  2. PBMWW vs MAS Comparison

PBMWW vs MAS Comparison

Compare PBMWW & MAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • MAS
  • Stock Information
  • Founded
  • PBMWW N/A
  • MAS 1929
  • Country
  • PBMWW Canada
  • MAS United States
  • Employees
  • PBMWW 10
  • MAS N/A
  • Industry
  • PBMWW
  • MAS Industrial Specialties
  • Sector
  • PBMWW
  • MAS Industrials
  • Exchange
  • PBMWW Nasdaq
  • MAS Nasdaq
  • Market Cap
  • PBMWW N/A
  • MAS N/A
  • IPO Year
  • PBMWW N/A
  • MAS N/A
  • Fundamental
  • Price
  • PBMWW $0.02
  • MAS $78.20
  • Analyst Decision
  • PBMWW
  • MAS Buy
  • Analyst Count
  • PBMWW 0
  • MAS 13
  • Target Price
  • PBMWW N/A
  • MAS $86.63
  • AVG Volume (30 Days)
  • PBMWW N/A
  • MAS 1.3M
  • Earning Date
  • PBMWW N/A
  • MAS 02-11-2025
  • Dividend Yield
  • PBMWW N/A
  • MAS 1.48%
  • EPS Growth
  • PBMWW N/A
  • MAS 2.74
  • EPS
  • PBMWW N/A
  • MAS 3.76
  • Revenue
  • PBMWW N/A
  • MAS $7,882,000,000.00
  • Revenue This Year
  • PBMWW N/A
  • MAS N/A
  • Revenue Next Year
  • PBMWW N/A
  • MAS $0.85
  • P/E Ratio
  • PBMWW N/A
  • MAS $20.81
  • Revenue Growth
  • PBMWW N/A
  • MAS N/A
  • 52 Week Low
  • PBMWW N/A
  • MAS $63.81
  • 52 Week High
  • PBMWW N/A
  • MAS $86.70
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • MAS 61.59
  • Support Level
  • PBMWW N/A
  • MAS $76.09
  • Resistance Level
  • PBMWW N/A
  • MAS $78.50
  • Average True Range (ATR)
  • PBMWW 0.00
  • MAS 1.44
  • MACD
  • PBMWW 0.00
  • MAS 0.87
  • Stochastic Oscillator
  • PBMWW 0.00
  • MAS 94.60

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: